Induced Autism: The Legal and Ethical Implications of Inoculating Vaccine Manufacturers from Liability

This document cites

• Federal Cases - 240 F.Supp.2d 191 (E.D.N.Y. 2002), CV 02-2018, Wax v. Aventis Pasteur Inc.
• Federal Cases - 807 F.2d 464 (5th Cir. 1987), 85-4894, Swayze v. McNeil Laboratories, Inc.
• Federal Cases - 270 F.Supp.2d 1368 (N.D.Ga. 2003), 02-CV-2257, Murphy v. Aventis Pasteur, Inc.
• Federal Cases - 291 F.Supp.2d 406 (M.D.N.C. 2003), 1 02CV01087, Laughter v. Aventis Pasteur, Inc.
• Federal Cases - 335 F.Supp.2d 614 (M.D.N.C. 2004), 1 03CV00669, John and Jane Doe 2 v. Ortho-Clinical Diagnostics, Inc.



See all quotations

• Federal Cases - 381 F.3d 501 (5th Cir. 2004), 03-30958, Moss v. Merck & Co.
• Federal Cases - 545 F.Supp. 306 (N.D.Cal. 1982), C-78-2041, Cook v. United States
• Federal Cases - 203 F.Supp.2d 748 (S.D.Tex. 2002), Civ. A.G-02-185, Owens ex rel. Schafer v. American Home Products Corp.
• Federal Cases - 208 F.Supp.2d 711 (S.D.Tex. 2002), Civ. A. G-02-226, Strauss v. American Home Products Corp.
• Federal Cases - 328 F.Supp.2d 647 (S.D.Tex. 2004), G-02-179, Blackmon v. American Home Products Corp.
• Federal Cases - 358 F.Supp.2d 574 (E.D.Tex. 2005), Civ. A. 503-CV-141, Easter v. Aventis Pasteur, Inc.
• Federal Cases - 293 F. 1013 (D.D.C. 1923), 3968, Frye v. United States
• Federal Cases - 940 F.2d 1518 (Fed. Cir. 1991), 91-5027, Hines on Behalf of Sevier v. Secretary of Dept. of Health and Human Services
• Federal Cases - 993 F.2d 1525 (Fed. Cir. 1993), 92-5172, Cucuras v. Secretary of Dept. of Health and Human Services
• Federal Cases - 165 F.3d 1344 (Fed. Cir. 1999), 98-5078, Shyface v. Secretary, Health and Human Services
• Federal Cases - 35 F.3d 543 (Fed. Cir. 1994), 93-5107, Knudsen by Knudsen v. Secretary of Dept. of Health and Human Services
• Federal Cases - 467 U.S. 837 (1984), 82-1005, Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc.
• Federal Cases - 492 U.S. 33 (1989), 87-1716, Granfinanciera, S.A. v. Nordberg
• Federal Cases - 509 U.S. 579 (1993), 92-102, Daubert v. Merrell Dow Pharmaceuticals
• Federal Cases - 514 U.S. 268 (1995), 94-372, Shalala v. Whitecotton
• Federal Cases - 523 U.S. 303 (1998), 96-1133, United States v. Scheffer
• Illinois - 777 N.E.2d 974 (Ill.App. 3 Dist. 2002), 3-01-0624, Dickey v. Connaught Laboratories, Inc.
• Nebraska - 597 N.W.2d 377 (Neb. 1999), S-97-1263, Phillips v. Industrial Machine
• New Jersey - 775 A.2d 528 (N.J.Super.A.D. 2001), McDonald v. Lederle Laboratories
• New Jersey - 864 A.2d 1147 (N.J.Super.A.D. 2005), Troxclair ex rel. Troxclair v. Aventis Pasteur, Inc.
• Pennsylvania - 843 A.2d 1258 (Pa.Super. 2004), Cheskiewicz v. Aventis Pasteur, Inc.
• Pennsylvania - 851 A.2d 908 (Pa.Super. 2004), Ashton v. Aventis Pasteur, Inc.
• Code of Federal Regulations - Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses
• Code of Federal Regulations - Constituent materials
• US Code - 21 U.S.C. § 351 Adulterated Drugs and Devices
• US Code - 21 U.S.C. § 361 Adulterated Cosmetics
• US Code - 21 U.S.C. § 393 Food and Drug Administration